Clinical Trial Update: Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluated whether Fluoroestradiol PET imaging can predict response to hormone therapy in metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fluoroestradiol (FES) radiotracer (fluoroestradiol)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Metastatic Breast Cancer | NA | Status: COMPLETED